Siemens Healthineers
Siemens Healthineers AG is a German medical technology company providing diagnostic imaging systems, radiation therapy equipment, and laboratory diagnostics globally. The enterprise designs and manufactures magnetic resonance scanners, computed tomography systems, molecular imaging platforms, radiation oncology systems, and immunoassay laboratory analyzers. Its primary revenue drivers stem from capital equipment sales, high-margin laboratory reagents and diagnostic consumables, and multi-year software and maintenance service contracts. Siemens Healthineers holds a world-leading market position in diagnostic imaging systems and cancer therapy solutions. The organization operates through four primary business segments: Imaging, Advanced Therapies, Diagnostics, and Varian. Its primary end markets encompass hospitals, medical research institutions, outpatient diagnostic centers, and clinical laboratories worldwide. Headquarters are located in Erlangen, Germany. Siemens Healthineers is publicly traded on the Frankfurt Stock Exchange.
40 of the funds FundTelligence covers report a position in Siemens Healthineers.
- Legal name
- Siemens Healthineers AG
- Sector
- Health Care
- Country
- Germany
- Funds holding it
- 40
- Exposure themes
- Medical technology, Prevention, Women's Health
Funds holding Siemens Healthineers
- Aktie-Ansvar Europa — Aktie-Ansvar · 3.25 % (full portfolio disclosed, June 2026)
- DNB Health Care — DNB · 2.1 % (full portfolio disclosed, September 2026)
- Storebrand Like Muligheter — Storebrand · 2.1 % (full portfolio disclosed, October 2026)
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 0.85 % (full portfolio disclosed, October 2026)
- DNB Fund Women's Health — DNB · 0.51 % (full portfolio disclosed, August 2026)
- Storebrand Europe Index — Storebrand · 0.17 % (full portfolio disclosed, October 2026)
- Storebrand Europa Plus — Storebrand · 0.16 % (full portfolio disclosed, October 2026)
- BlackRock iShares MSCI Europe Screened UCITS ETF — BlackRock · 0.14 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 40 funds holding it.